在药物过度使用头痛中添加皮质类固醇加尔坎祖马布:一个三臂头对头前性观察队列研究
S Braca1, R De Simone1, A Stornaiuolo1
1Department of Neurological Sciences, Reproductive and Odontostomatological Sciences, University Federico II, 80131 Naples, Italy.
Revue neurologique
|November 7, 2024
概括
这项研究发现,加尔坎祖马布和普雷尼松都有效治疗药物过量使用头痛 (MOH). 结合加尔坎祖马布和普雷尼松产生了最好的结果,尽管普雷尼松引起了更多的副作用.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物过度使用头痛 (MOH) 是一种慢性疾病,是由过度使用止痛药引起的.
- 预防性治疗,包括抗CGRP单克隆抗体,显示出MOH管理的前景.
- 皮质类固醇传统上用于缓解MOH治疗期间的戒断症状.
研究的目的:
- 为了比较单独使用加尔干祖马布,加尔干祖马布加普得尼松,单独使用普得尼松治疗的有效性和安全性.
- 为了评估不同治疗手臂的头痛频率减少和不良事件.
主要方法:
- 一项前性,三臂观察性队列研究,涉及75名MOH患者.
- 治疗包括加尔坎祖马布单独治疗,联合治疗 (加尔坎祖马布+普得尼松) 和普得尼松单独治疗.
- 普雷尼松每天服用50毫克,在28天内逐渐减少,随访3个月.
主要成果:
- 所有治疗组都显示每月头痛日数显著减少 (P<0.001).
- 加尔坎祖马布加普雷尼松组经历了最大的减少 (25到7天).
- 与其他组相比,单独治疗普雷尼松导致更多的副作用报告 (P=0.002).
结论:
- 加尔坎祖马布和普雷尼松都有效降低MOH患者头痛的频率.
- 与加尔坎祖马布和普得尼松的联合治疗提供了最显著的头痛减轻.
- 普雷尼松与较高的不良事件发生率有关,这表明它主要用于不响应病例; 甘祖马布对于大多数患者来说是一种安全有效的替代方案.
更多相关视频
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96
01:27Open Angle Glaucoma: Treatment
393
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
393
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
222
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
222
01:28Angle Closure Glaucoma: Treatment
438
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
438
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
01:29Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120